Public health burden due to infections by verocytotoxin-producing Escherichia coli (VTEC) and Campylobacter spp. as estimated by cost of illness and different approaches to model disability-adjusted life years

Scandinavian Journal of Public Health

Volumn 40, Issue 3, 2012, Pages 294-302

  Toljander, Jonas ^a   Dovärn, Anna ^a   Andersson, Yvonne ^b   Ivarsson, Sofie ^b   Lindqvist, Roland ^b  

^a National Food Agency   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Campylobacter; cost of illness (COI); disability adjusted life years (DALY); disease burden; economic burden; enterohaemorrhagic Escherichia coli (EHEC); gastroenteritis; public health burden; shigatoxin producing Escherichia coli (STEC); verocytotoxin producing Escherichia coli (VTEC)

Indexed keywords

ARTICLE; CAMPYLOBACTERIOSIS; COST OF ILLNESS; ECONOMICS; ESCHERICHIA COLI INFECTION; HUMAN; PUBLIC HEALTH; QUALITY ADJUSTED LIFE YEAR; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SWEDEN;

CAMPYLOBACTER INFECTIONS; COST OF ILLNESS; ESCHERICHIA COLI INFECTIONS; HUMANS; PUBLIC HEALTH; QUALITY-ADJUSTED LIFE YEARS; SHIGA-TOXIGENIC ESCHERICHIA COLI; SWEDEN;

EID: 84861802711     PISSN: 14034948     EISSN: 16511905     Source Type: Journal    
DOI: 10.1177/1403494811435495     Document Type: Article

References (27)

1. Swedish Institute for Infectious Disease Control. Smi Net – electronic system for communicable diseases surveillance [database on the internet]. Stockholm: Swedish Institute for Infectious Disease Control (SMI), 2008.
2. Mead P.S. Slutsker L. Dietz V. McCaig L.F. Bresee J.S. Shapiro C. et al. Food-related illness and death in the United States. Emerg Infect Dis 1999;5(5):607–25.
3. Adak G.K. Long S.M. O'Brien S.J. Trends in indigenous foodborne disease and deaths, England and Wales: 1992 to 2000. Gut 2002;51(6):832–41.
4. Murray C.J.L. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 1994;72(3):429–45.
5. Frenzen P.D. Drake A. Angulo F.J. ; Emerging Infections Program FoodNet Working Group. Economic cost of illness due to Escherichia coli O 157 infections in the United States. J Food Prot 2005;68(12):2623–30.
6. Mangen M.J.J. Havelaar A.H. Bernsen Rajam van Koningsveld R. de Wit G.A. The costs of human Campylobacter infections and sequelae in the Netherlands: a DALY and cost-of-illness approach. Acta Agric Scand Section C 2005;2(1):35–51.
7. Sundström K. Campylobacteriosis and salmonellosis in Sweden – an estimation of direct and indirect costs [Campylobacterios och salmonellos i Sverige – en beräkning av direkta och indirekta kostnader][in Swedish]. Lund, Sweden: Livsmedelsekonomiska institutet (SLI), 2007. Report no: 2007:1.
8. Havelaar A.H. de Wit M.A. van Koningsveld R. van Kempen E. Health burden in the Netherlands due to infection with thermophilic Campylobacter spp. Epidemiol Infect 2000;125(3):505–22.
9. Havelaar A.H. van Duynhoven Y.T. Nauta M.J. Bouwknegt M. Heuvelink A.E. de Wit G.A. et al. Disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157. Epidemiol Infect 2004;132(3):467–84.
10. Tariq L. Haagsma J. Havelaar A. Cost of illness and disease burden in the Netherlands due to infections with shiga toxin-producing Escherichia coli O157. J Food Prot 2011;74(4):545–52.
11. Cressey P. Lake R. Risk ranking: Estimates of the burden of foodborne disease for New Zealand. Christchurch, New Zealand: Institute of Environmental Science & Research, Christchurch Science Centre, 2007. Report no: client report FW0724.
12. van Lier E.A. Havelaar A. Nanda A. The burden of infectious diseases in Europe: a pilot study. Eurosurveillance. 2007; Available from: http://www.eurosurveillance.org/em/v12n12/1212–222.asp.
13. Kuchenmüller T. Hird S. Stein C. Kramarz P. Nanda A. Havelaar A.H. Estimating the global burden of foodborne diseases – a collaborative effort. Stockholm: Eurosurveillance. Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19195 [2009].
14. Moradi T. Allebeck P. Jacobsson A. Mathers C. The burden of disease in Sweden measured with DALY. Neuropsychiatric diseases and cardiovascular diseases dominate [Sjukdomsbördan i Sverige mätt med DALY: Neuropsykiatriska sjukdomar och hjärt-kärlsjukdomar dominerar, in Swedish]. Läkartidningen 2006;103(3):137–41.
15. Lindqvist R. Andersson Y. Lindbäck J. Wegscheider M. Eriksson Y. Tideström L. et al. A one-year study of foodborne illnesses in the municipality of Uppsala, Sweden. Emerg Infect Dis 2001;7(3 Suppl):588–92.
16. Swedish Association of Local Authorities and Regions. Cost per patient (KPP) database [database on the internet]. Available at: http://www.skl.se/ [2008, consulted March 2008].
17. National Board of Health and Welfare. Statistical databases [database on the internet]. Stockholm: NBHW. Available at: http://www.socialstyrelsen.se/Statistics/ [2008, consulted March 2008].
18. Mangen M.J.J. Havelaar A.H. de Wit G.A. Campylobacteriosis and sequelae in the Netherlands, estimating the disease burden and the cost-of-illness. Bilthoven, The Netherlands: National Institute for Public Health and Environment (RIVM), 2004. Report no: 250911 / 004.
19. Statistics Sweden.Statistical database [database on the internet]. Available at: http://www.ssd.scb.se [2008, consulted March 2008].
20. Andersson Y. Normann B. Tideström L. Communicable diseases [Fakta om smittsamma sjukdomar] [in Swedish]. Stockholm: Swedish Institute for Infectious Disease Control, The Swedish Society for Communicable Disease Prevention and Control, 2005.
21. Toljander J. Karnehed N. Behavioural patterns associated with gastrointestinal- and foodborne gastrointestinal illness – results from an interview-based survey in Sweden [Vad gör de som drabbas av magsjuka och matförgiftningar? – resultat från en nationell intervjuundersökning] [in Swedish, summary in English]. Uppsala: National Food Administration, 2010.
22. van Pelt W. de Wit M.A. Wannet W.J. Ligtvoet E.J. Widdowson M.A. van Duynhoven Y.T. Laboratory surveillance of bacterial gastroenteric pathogens in The Netherlands, 1991–2001. Epidemiol Infect 2003;130(3):431–41.
23. Wheeler J.G. Sethi D. Cowden J.M. Wall P.G. Rodrigues L.C. Tompkins D.S. et al. Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. the Infectious Intestinal Disease Study Executive. Br Med J 1999;318(7190):1046–50.
24. Kemmeren J.M. Mangen M.-J.J. van Duynhoven Y.T.H.P. Havelaar A.H. Priority setting of foodborne pathogens disease burden and costs of selected enteric pathogens. Bilthoven, The Netherlands: National Institute for Public Health and Environment (RIVM), 2006. Report no: 330080001 / 2006.
25. Pires S.M. Evers E.G. van Pelt W. Ayers T. Scallan E. Angulo F.J. et al. Attributing the human disease burden of foodborne infections to specific sources. Foodborne Pathog Dis 2009;6(4):417–24.
26. Karpman D. Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Current perspectives on EHEC, complement mutations and ADAMTS 13 [Nya rön om EHEC, komplementmutationer och ADAMTS 13, in Swedish]. Läkartidningen 2008;105(15):1096–101.
27. McCarthy N. Giesecke J. Incidence of Guillain-Barré syndrome following infection with Campylobacter jejuni. Am J Epidemiol 2001;153(6):610–14.